Monday, June 30, 2025 6/30/2025

Using Common Fund datasets for prioritization of disease-associated genetic variants

Award Number: R03OD034494
ORGANIZATION: OFFICE OF THE DIRECTOR, NIH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/20/2022
PERIOD OF PERFORMANCE END DATE: 09/19/2024

Group Awards By:

View Award Description

Using Common Fund datasets for prioritization of disease-associated genetic variants - Abstract Genome-wide association studies (GWAS) have highlighted that disease-associated human genetic variants are prevalent in noncoding regions and for most of them the biological function or gene target remain uncharacterized. To better annotate such disease variants, NIH-funded consortia created comprehensive maps of putative regulatory elements and identified SNPs associated with gene expression (eQTLs) for different tissues and primary cell types. In parallel, breakthroughs in capturing the 3D genome structure have demonstrated the importance of cell-type-specific physical proximity between genes and their regulatory elements. This 3D view provided a new way through which disease-associations of certain variants can be explained. There is an increasing interest in utilization of chromatin loops for GWAS variant annotation, however, to the best of our knowledge, there is no comprehensive study incorporating eQTL data and high-resolution chromatin looping information across many different matched/related cell types and tissues to interpret GWAS variants identified for a large set of diseases. To goal of this proposal is to utilize NIH Common Fund datasets (GTEx and 4D Nucleome) as well as other published chromatin loop and eQTL data to carry out different integrative approaches for better annotation of disease-associated genetic variants. This will lead to the development of a framework and best practices for integrative analysis of loops, eQTLs and GWAS signals. The developed framework will be tested on a large number of diseases and disease-relevant cell types to create a substantial online resource for researchers. For a subset of the studied diseases, for which we have ongoing research interests, we will further analyze the identified novel genes, genetic variants and overlapping regulatory elements to determine potential targets that warrant further investigation.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2022	LA JOLLA INSTITUTE FOR IMMUNOLOGY	9420 ATHENA CIR	LA JOLLA	CA	92037	SAN DIEGO	USA	Trans-NIH Research Support	000	1	12/30/2024	NEW	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $366,000 )
2022	2022	LA JOLLA INSTITUTE FOR IMMUNOLOGY	9420 ATHENA CIR	LA JOLLA	CA	92037	SAN DIEGO	USA	Trans-NIH Research Support	000	1	9/20/2022	NEW	$366,000
														Subtotal = $366,000

Grand Total All Awards = $366,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Using Common Fund datasets for prioritization of disease-associated genetic variants

Award Number: R03OD034494

ORGANIZATION: OFFICE OF THE DIRECTOR, NIH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/20/2022

PERIOD OF PERFORMANCE END DATE: 09/19/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer